Cardiopulmonary Effects of Prone Position in CARDS

Status Completed

Clinical Trial Summary

In coronavirus disease-2019 (COVID-19)-related ARDS (C-ARDS), especially in the severe form, increased shunt rate, impaired ventilation/perfusion ratio (V/Q), hypoxic pulmonary vasoconstriction inhibition, and increased immune microthrombosis may have similar effects on the right ventricle .The cardiopulmonary pathophysiology and outcomes of C-ARDS vary, and this variability requires monitoring to follow the diagnosis and treatment process. This study aimed to increase the treatment success of the prone position in C-ARDS and to provide a prognostic factor for survival by analyzing and monitoring heart-lung interactions. Therefore, we used transesophageal echocardiography (TEE) to evaluate the cardiopulmonary effects of prone position.

Clinical Trial Description

This prospective study included 30 moderate-to-severe C-ARDS patients who were treated with prone position in the first 48 hours of invasive mechanical ventilation support. It was evaluated with transesophageal echocardiography three times: before prone position (PP) (T0), the first hour of PP (T1), and the first hour of returning to the supine position (T0 + 24 hours) (T2) after 23 hours prone position treatment. Right ventricular end-diastolic area/left ventricular end-diastolic area (RVEDA/LVEDA) was preferred right ventricular evaluations as primer outcome. Static compliance (C-stat) was examined in the evaluation of the pulmonary effect of prone position as secondary outcome. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT06456606
Study type	Observational [Patient Registry]
Source	Bakirkoy Dr. Sadi Konuk Research and Training Hospital
Contact
Status	Completed
Phase
Start date	February 1, 2022
Completion date	May 30, 2022

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03183414` - Right Ventricular Dysfunction in Cardiac Surgery Patients
Recruiting	`NCT04764032` - Right Ventricular Dysfunction in Ventilated Patients With COVID-19
Not yet recruiting	`NCT05188222` - Preoperative Maltodextrin's Effect on Cardiac Function in Cardiac Surgery	Phase 4
Not yet recruiting	`NCT06002321` - Right Ventricular Dysfunction in Chronic Heart Failure
Completed	`NCT05948332` - Definition and Management of Right Ventricular Injury in Adult Patients Receiving Extracorporeal Membrane Oxygenation
Recruiting	`NCT03309852` - Emergency Department Assessment of Right Ventricular Function and Size in the Post Cardiac Arrest Patient
Recruiting	`NCT05583461` - Ventilator-induced Right Ventricular Injury During EIT-based PEEP Titration in Patients With ARDS	N/A
Completed	`NCT03438825` - PRediction of Early PostoperAtive Right vEntricular Failure in Mitral Valve Replacement/Repair Patients
Active, not recruiting	`NCT01230294` - New Echocardiographic Methods for Right Ventricular Function.	N/A
Completed	`NCT00557934` - Right Ventricular Contractility Reserve Following Repair of Tetralogy of Fallot	N/A
Completed	`NCT04694378` - Relationship Between Strain and Stroke Volume in Cardiac Surgery
Not yet recruiting	`NCT04167241` - Right Ventricle Function After Major Right Lung Resection
Recruiting	`NCT03013075` - General Plus Spinal Anesthesia and General Anesthesia Alone on Right Ventricular Function	Phase 4
Completed	`NCT06197256` - Cardiac Dysfunction in Critically Ill Covid-19 Patients
Completed	`NCT03301571` - Right Ventricular Echocardiography in caRdiac SurgEry	N/A
Recruiting	`NCT05860504` - Acute Cardiac Dysfunction in Critical Illnes
Completed	`NCT01093001` - Tricuspid Regurgitation Study	Phase 4
Recruiting	`NCT05758194` - Mitigating Post-Op RV Dysfunction After LVAD Implantation	N/A
Not yet recruiting	`NCT05768230` - Using TEE to Evaluate the Effect of Levosimendan on Patients With ARDS Associated With RVD During MV	Phase 2/Phase 3
Not yet recruiting	`NCT05620992` - Evaluation of Right Ventricular Function Post Mitral Valve Operations